nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP3A4—Fingolimod—multiple sclerosis	0.106	0.172	CbGbCtD
Guanfacine—CYP2C19—Prednisone—multiple sclerosis	0.0858	0.139	CbGbCtD
Guanfacine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0685	0.111	CbGbCtD
Guanfacine—CYP2C19—Dexamethasone—multiple sclerosis	0.0536	0.0869	CbGbCtD
Guanfacine—CYP3A4—Triamcinolone—multiple sclerosis	0.0519	0.0842	CbGbCtD
Guanfacine—CYP3A4—Mitoxantrone—multiple sclerosis	0.05	0.081	CbGbCtD
Guanfacine—CYP2C9—Dexamethasone—multiple sclerosis	0.0445	0.0723	CbGbCtD
Guanfacine—CYP3A4—Betamethasone—multiple sclerosis	0.0445	0.0722	CbGbCtD
Guanfacine—CYP3A4—Prednisolone—multiple sclerosis	0.0439	0.0713	CbGbCtD
Guanfacine—CYP3A4—Prednisone—multiple sclerosis	0.0415	0.0673	CbGbCtD
Guanfacine—CYP3A4—Dexamethasone—multiple sclerosis	0.0259	0.042	CbGbCtD
Guanfacine—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000679	0.00181	CcSEcCtD
Guanfacine—Constipation—Mitoxantrone—multiple sclerosis	0.000679	0.00181	CcSEcCtD
Guanfacine—Bradycardia—Prednisone—multiple sclerosis	0.000678	0.00181	CcSEcCtD
Guanfacine—Alopecia—Dexamethasone—multiple sclerosis	0.000676	0.0018	CcSEcCtD
Guanfacine—Alopecia—Betamethasone—multiple sclerosis	0.000676	0.0018	CcSEcCtD
Guanfacine—Diarrhoea—Azathioprine—multiple sclerosis	0.000672	0.00179	CcSEcCtD
Guanfacine—Discomfort—Prednisolone—multiple sclerosis	0.000671	0.00179	CcSEcCtD
Guanfacine—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000666	0.00178	CcSEcCtD
Guanfacine—Hallucination—Prednisone—multiple sclerosis	0.000663	0.00177	CcSEcCtD
Guanfacine—Malaise—Triamcinolone—multiple sclerosis	0.000662	0.00177	CcSEcCtD
Guanfacine—Malaise—Methylprednisolone—multiple sclerosis	0.00066	0.00176	CcSEcCtD
Guanfacine—Vertigo—Triamcinolone—multiple sclerosis	0.000659	0.00176	CcSEcCtD
Guanfacine—Syncope—Triamcinolone—multiple sclerosis	0.000658	0.00176	CcSEcCtD
Guanfacine—Vertigo—Methylprednisolone—multiple sclerosis	0.000658	0.00176	CcSEcCtD
Guanfacine—Syncope—Methylprednisolone—multiple sclerosis	0.000656	0.00175	CcSEcCtD
Guanfacine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000654	0.00175	CcSEcCtD
Guanfacine—Oedema—Prednisolone—multiple sclerosis	0.000651	0.00174	CcSEcCtD
Guanfacine—Dizziness—Azathioprine—multiple sclerosis	0.000649	0.00173	CcSEcCtD
Guanfacine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000649	0.00173	CcSEcCtD
Guanfacine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000645	0.00172	CcSEcCtD
Guanfacine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000643	0.00172	CcSEcCtD
Guanfacine—Shock—Prednisolone—multiple sclerosis	0.00064	0.00171	CcSEcCtD
Guanfacine—Erectile dysfunction—Methotrexate—multiple sclerosis	0.00064	0.00171	CcSEcCtD
Guanfacine—Convulsion—Triamcinolone—multiple sclerosis	0.000636	0.0017	CcSEcCtD
Guanfacine—Tachycardia—Prednisolone—multiple sclerosis	0.000635	0.0017	CcSEcCtD
Guanfacine—Convulsion—Methylprednisolone—multiple sclerosis	0.000634	0.00169	CcSEcCtD
Guanfacine—Hypertension—Triamcinolone—multiple sclerosis	0.000633	0.00169	CcSEcCtD
Guanfacine—Hypertension—Methylprednisolone—multiple sclerosis	0.000632	0.00169	CcSEcCtD
Guanfacine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000629	0.00168	CcSEcCtD
Guanfacine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000627	0.00168	CcSEcCtD
Guanfacine—Myalgia—Triamcinolone—multiple sclerosis	0.000625	0.00167	CcSEcCtD
Guanfacine—Vomiting—Azathioprine—multiple sclerosis	0.000624	0.00167	CcSEcCtD
Guanfacine—Myalgia—Methylprednisolone—multiple sclerosis	0.000623	0.00166	CcSEcCtD
Guanfacine—Arthralgia—Methylprednisolone—multiple sclerosis	0.000623	0.00166	CcSEcCtD
Guanfacine—Eye disorder—Prednisone—multiple sclerosis	0.000622	0.00166	CcSEcCtD
Guanfacine—Anxiety—Methylprednisolone—multiple sclerosis	0.000621	0.00166	CcSEcCtD
Guanfacine—Drowsiness—Methotrexate—multiple sclerosis	0.00062	0.00166	CcSEcCtD
Guanfacine—Rash—Azathioprine—multiple sclerosis	0.000619	0.00165	CcSEcCtD
Guanfacine—Dermatitis—Azathioprine—multiple sclerosis	0.000618	0.00165	CcSEcCtD
Guanfacine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000618	0.00165	CcSEcCtD
Guanfacine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000618	0.00165	CcSEcCtD
Guanfacine—Discomfort—Triamcinolone—multiple sclerosis	0.000617	0.00165	CcSEcCtD
Guanfacine—Discomfort—Methylprednisolone—multiple sclerosis	0.000616	0.00164	CcSEcCtD
Guanfacine—Headache—Azathioprine—multiple sclerosis	0.000615	0.00164	CcSEcCtD
Guanfacine—Dry mouth—Triamcinolone—multiple sclerosis	0.000611	0.00163	CcSEcCtD
Guanfacine—Conjunctivitis—Methotrexate—multiple sclerosis	0.000603	0.00161	CcSEcCtD
Guanfacine—Confusional state—Methylprednisolone—multiple sclerosis	0.000602	0.00161	CcSEcCtD
Guanfacine—Immune system disorder—Prednisone—multiple sclerosis	0.000601	0.00161	CcSEcCtD
Guanfacine—Malaise—Betamethasone—multiple sclerosis	0.0006	0.0016	CcSEcCtD
Guanfacine—Malaise—Dexamethasone—multiple sclerosis	0.0006	0.0016	CcSEcCtD
Guanfacine—Oedema—Triamcinolone—multiple sclerosis	0.000599	0.0016	CcSEcCtD
Guanfacine—Vertigo—Dexamethasone—multiple sclerosis	0.000598	0.0016	CcSEcCtD
Guanfacine—Vertigo—Betamethasone—multiple sclerosis	0.000598	0.0016	CcSEcCtD
Guanfacine—Syncope—Betamethasone—multiple sclerosis	0.000597	0.00159	CcSEcCtD
Guanfacine—Syncope—Dexamethasone—multiple sclerosis	0.000597	0.00159	CcSEcCtD
Guanfacine—Sweating—Methotrexate—multiple sclerosis	0.000594	0.00159	CcSEcCtD
Guanfacine—Shock—Triamcinolone—multiple sclerosis	0.000589	0.00157	CcSEcCtD
Guanfacine—Insomnia—Prednisolone—multiple sclerosis	0.000589	0.00157	CcSEcCtD
Guanfacine—Alopecia—Prednisone—multiple sclerosis	0.000588	0.00157	CcSEcCtD
Guanfacine—Shock—Methylprednisolone—multiple sclerosis	0.000588	0.00157	CcSEcCtD
Guanfacine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000585	0.00156	CcSEcCtD
Guanfacine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000585	0.00156	CcSEcCtD
Guanfacine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000585	0.00156	CcSEcCtD
Guanfacine—Paraesthesia—Prednisolone—multiple sclerosis	0.000585	0.00156	CcSEcCtD
Guanfacine—Tachycardia—Triamcinolone—multiple sclerosis	0.000584	0.00156	CcSEcCtD
Guanfacine—Nausea—Azathioprine—multiple sclerosis	0.000583	0.00156	CcSEcCtD
Guanfacine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000583	0.00156	CcSEcCtD
Guanfacine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000579	0.00155	CcSEcCtD
Guanfacine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000577	0.00154	CcSEcCtD
Guanfacine—Convulsion—Dexamethasone—multiple sclerosis	0.000577	0.00154	CcSEcCtD
Guanfacine—Convulsion—Betamethasone—multiple sclerosis	0.000577	0.00154	CcSEcCtD
Guanfacine—Hypertension—Betamethasone—multiple sclerosis	0.000575	0.00154	CcSEcCtD
Guanfacine—Hypertension—Dexamethasone—multiple sclerosis	0.000575	0.00154	CcSEcCtD
Guanfacine—Asthenia—Mitoxantrone—multiple sclerosis	0.000569	0.00152	CcSEcCtD
Guanfacine—Myalgia—Betamethasone—multiple sclerosis	0.000567	0.00151	CcSEcCtD
Guanfacine—Myalgia—Dexamethasone—multiple sclerosis	0.000567	0.00151	CcSEcCtD
Guanfacine—Anxiety—Dexamethasone—multiple sclerosis	0.000565	0.00151	CcSEcCtD
Guanfacine—Anxiety—Betamethasone—multiple sclerosis	0.000565	0.00151	CcSEcCtD
Guanfacine—Discomfort—Betamethasone—multiple sclerosis	0.00056	0.0015	CcSEcCtD
Guanfacine—Discomfort—Dexamethasone—multiple sclerosis	0.00056	0.0015	CcSEcCtD
Guanfacine—Hypotension—Methylprednisolone—multiple sclerosis	0.000558	0.00149	CcSEcCtD
Guanfacine—Vision blurred—Prednisone—multiple sclerosis	0.000546	0.00146	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000545	0.00146	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000544	0.00145	CcSEcCtD
Guanfacine—Oedema—Dexamethasone—multiple sclerosis	0.000543	0.00145	CcSEcCtD
Guanfacine—Oedema—Betamethasone—multiple sclerosis	0.000543	0.00145	CcSEcCtD
Guanfacine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000543	0.00145	CcSEcCtD
Guanfacine—Insomnia—Triamcinolone—multiple sclerosis	0.000541	0.00145	CcSEcCtD
Guanfacine—Insomnia—Methylprednisolone—multiple sclerosis	0.00054	0.00144	CcSEcCtD
Guanfacine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000538	0.00144	CcSEcCtD
Guanfacine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000538	0.00144	CcSEcCtD
Guanfacine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000536	0.00143	CcSEcCtD
Guanfacine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000536	0.00143	CcSEcCtD
Guanfacine—Visual impairment—Methotrexate—multiple sclerosis	0.000536	0.00143	CcSEcCtD
Guanfacine—Shock—Dexamethasone—multiple sclerosis	0.000534	0.00143	CcSEcCtD
Guanfacine—Shock—Betamethasone—multiple sclerosis	0.000534	0.00143	CcSEcCtD
Guanfacine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000534	0.00143	CcSEcCtD
Guanfacine—Agitation—Prednisone—multiple sclerosis	0.000533	0.00142	CcSEcCtD
Guanfacine—Tachycardia—Dexamethasone—multiple sclerosis	0.00053	0.00142	CcSEcCtD
Guanfacine—Tachycardia—Betamethasone—multiple sclerosis	0.00053	0.00142	CcSEcCtD
Guanfacine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000527	0.00141	CcSEcCtD
Guanfacine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000526	0.0014	CcSEcCtD
Guanfacine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000525	0.0014	CcSEcCtD
Guanfacine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000525	0.0014	CcSEcCtD
Guanfacine—Malaise—Prednisone—multiple sclerosis	0.000523	0.0014	CcSEcCtD
Guanfacine—Vertigo—Prednisone—multiple sclerosis	0.000521	0.00139	CcSEcCtD
Guanfacine—Eye disorder—Methotrexate—multiple sclerosis	0.00052	0.00139	CcSEcCtD
Guanfacine—Syncope—Prednisone—multiple sclerosis	0.00052	0.00139	CcSEcCtD
Guanfacine—Tinnitus—Methotrexate—multiple sclerosis	0.000519	0.00139	CcSEcCtD
Guanfacine—Fatigue—Triamcinolone—multiple sclerosis	0.000516	0.00138	CcSEcCtD
Guanfacine—Fatigue—Methylprednisolone—multiple sclerosis	0.000515	0.00138	CcSEcCtD
Guanfacine—Loss of consciousness—Prednisone—multiple sclerosis	0.000509	0.00136	CcSEcCtD
Guanfacine—Hypotension—Betamethasone—multiple sclerosis	0.000508	0.00136	CcSEcCtD
Guanfacine—Hypotension—Dexamethasone—multiple sclerosis	0.000508	0.00136	CcSEcCtD
Guanfacine—Vomiting—Mitoxantrone—multiple sclerosis	0.000505	0.00135	CcSEcCtD
Guanfacine—Immune system disorder—Methotrexate—multiple sclerosis	0.000503	0.00134	CcSEcCtD
Guanfacine—Convulsion—Prednisone—multiple sclerosis	0.000502	0.00134	CcSEcCtD
Guanfacine—Hypertension—Prednisone—multiple sclerosis	0.0005	0.00134	CcSEcCtD
Guanfacine—Rash—Mitoxantrone—multiple sclerosis	0.0005	0.00134	CcSEcCtD
Guanfacine—Dermatitis—Mitoxantrone—multiple sclerosis	0.0005	0.00134	CcSEcCtD
Guanfacine—Headache—Mitoxantrone—multiple sclerosis	0.000497	0.00133	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000495	0.00132	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000495	0.00132	CcSEcCtD
Guanfacine—Myalgia—Prednisone—multiple sclerosis	0.000493	0.00132	CcSEcCtD
Guanfacine—Arthralgia—Prednisone—multiple sclerosis	0.000493	0.00132	CcSEcCtD
Guanfacine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000493	0.00132	CcSEcCtD
Guanfacine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000492	0.00131	CcSEcCtD
Guanfacine—Anxiety—Prednisone—multiple sclerosis	0.000492	0.00131	CcSEcCtD
Guanfacine—Alopecia—Methotrexate—multiple sclerosis	0.000492	0.00131	CcSEcCtD
Guanfacine—Insomnia—Dexamethasone—multiple sclerosis	0.000491	0.00131	CcSEcCtD
Guanfacine—Insomnia—Betamethasone—multiple sclerosis	0.000491	0.00131	CcSEcCtD
Guanfacine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000488	0.0013	CcSEcCtD
Guanfacine—Paraesthesia—Betamethasone—multiple sclerosis	0.000488	0.0013	CcSEcCtD
Guanfacine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000488	0.0013	CcSEcCtD
Guanfacine—Discomfort—Prednisone—multiple sclerosis	0.000488	0.0013	CcSEcCtD
Guanfacine—Hypersensitivity—Prednisolone—multiple sclerosis	0.00048	0.00128	CcSEcCtD
Guanfacine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000478	0.00128	CcSEcCtD
Guanfacine—Dyspepsia—Betamethasone—multiple sclerosis	0.000478	0.00128	CcSEcCtD
Guanfacine—Dysgeusia—Methotrexate—multiple sclerosis	0.000474	0.00127	CcSEcCtD
Guanfacine—Oedema—Prednisone—multiple sclerosis	0.000473	0.00126	CcSEcCtD
Guanfacine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000472	0.00126	CcSEcCtD
Guanfacine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000472	0.00126	CcSEcCtD
Guanfacine—Decreased appetite—Betamethasone—multiple sclerosis	0.000472	0.00126	CcSEcCtD
Guanfacine—Nausea—Mitoxantrone—multiple sclerosis	0.000471	0.00126	CcSEcCtD
Guanfacine—Fatigue—Dexamethasone—multiple sclerosis	0.000468	0.00125	CcSEcCtD
Guanfacine—Fatigue—Betamethasone—multiple sclerosis	0.000468	0.00125	CcSEcCtD
Guanfacine—Shock—Prednisone—multiple sclerosis	0.000465	0.00124	CcSEcCtD
Guanfacine—Tachycardia—Prednisone—multiple sclerosis	0.000462	0.00123	CcSEcCtD
Guanfacine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000457	0.00122	CcSEcCtD
Guanfacine—Vision blurred—Methotrexate—multiple sclerosis	0.000457	0.00122	CcSEcCtD
Guanfacine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000449	0.0012	CcSEcCtD
Guanfacine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000448	0.0012	CcSEcCtD
Guanfacine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000448	0.0012	CcSEcCtD
Guanfacine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000444	0.00119	CcSEcCtD
Guanfacine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000444	0.00119	CcSEcCtD
Guanfacine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000441	0.00118	CcSEcCtD
Guanfacine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00044	0.00118	CcSEcCtD
Guanfacine—Malaise—Methotrexate—multiple sclerosis	0.000437	0.00117	CcSEcCtD
Guanfacine—Vertigo—Methotrexate—multiple sclerosis	0.000435	0.00116	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000431	0.00115	CcSEcCtD
Guanfacine—Dizziness—Prednisolone—multiple sclerosis	0.00043	0.00115	CcSEcCtD
Guanfacine—Asthenia—Triamcinolone—multiple sclerosis	0.00043	0.00115	CcSEcCtD
Guanfacine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000429	0.00115	CcSEcCtD
Guanfacine—Abdominal pain—Betamethasone—multiple sclerosis	0.000429	0.00115	CcSEcCtD
Guanfacine—Asthenia—Methylprednisolone—multiple sclerosis	0.000429	0.00114	CcSEcCtD
Guanfacine—Insomnia—Prednisone—multiple sclerosis	0.000428	0.00114	CcSEcCtD
Guanfacine—Paraesthesia—Prednisone—multiple sclerosis	0.000425	0.00113	CcSEcCtD
Guanfacine—Pruritus—Triamcinolone—multiple sclerosis	0.000424	0.00113	CcSEcCtD
Guanfacine—Pruritus—Methylprednisolone—multiple sclerosis	0.000423	0.00113	CcSEcCtD
Guanfacine—Convulsion—Methotrexate—multiple sclerosis	0.00042	0.00112	CcSEcCtD
Guanfacine—Dyspepsia—Prednisone—multiple sclerosis	0.000416	0.00111	CcSEcCtD
Guanfacine—Myalgia—Methotrexate—multiple sclerosis	0.000412	0.0011	CcSEcCtD
Guanfacine—Chest pain—Methotrexate—multiple sclerosis	0.000412	0.0011	CcSEcCtD
Guanfacine—Arthralgia—Methotrexate—multiple sclerosis	0.000412	0.0011	CcSEcCtD
Guanfacine—Decreased appetite—Prednisone—multiple sclerosis	0.000411	0.0011	CcSEcCtD
Guanfacine—Rash—Prednisolone—multiple sclerosis	0.00041	0.0011	CcSEcCtD
Guanfacine—Dermatitis—Prednisolone—multiple sclerosis	0.00041	0.0011	CcSEcCtD
Guanfacine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000409	0.00109	CcSEcCtD
Guanfacine—Fatigue—Prednisone—multiple sclerosis	0.000408	0.00109	CcSEcCtD
Guanfacine—Headache—Prednisolone—multiple sclerosis	0.000408	0.00109	CcSEcCtD
Guanfacine—Discomfort—Methotrexate—multiple sclerosis	0.000407	0.00109	CcSEcCtD
Guanfacine—Constipation—Prednisone—multiple sclerosis	0.000405	0.00108	CcSEcCtD
Guanfacine—Confusional state—Methotrexate—multiple sclerosis	0.000399	0.00106	CcSEcCtD
Guanfacine—Dizziness—Triamcinolone—multiple sclerosis	0.000396	0.00106	CcSEcCtD
Guanfacine—Dizziness—Methylprednisolone—multiple sclerosis	0.000395	0.00106	CcSEcCtD
Guanfacine—Feeling abnormal—Prednisone—multiple sclerosis	0.00039	0.00104	CcSEcCtD
Guanfacine—Asthenia—Betamethasone—multiple sclerosis	0.00039	0.00104	CcSEcCtD
Guanfacine—Asthenia—Dexamethasone—multiple sclerosis	0.00039	0.00104	CcSEcCtD
Guanfacine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000387	0.00103	CcSEcCtD
Guanfacine—Nausea—Prednisolone—multiple sclerosis	0.000387	0.00103	CcSEcCtD
Guanfacine—Pruritus—Betamethasone—multiple sclerosis	0.000384	0.00103	CcSEcCtD
Guanfacine—Pruritus—Dexamethasone—multiple sclerosis	0.000384	0.00103	CcSEcCtD
Guanfacine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000382	0.00102	CcSEcCtD
Guanfacine—Vomiting—Triamcinolone—multiple sclerosis	0.000381	0.00102	CcSEcCtD
Guanfacine—Vomiting—Methylprednisolone—multiple sclerosis	0.00038	0.00101	CcSEcCtD
Guanfacine—Rash—Triamcinolone—multiple sclerosis	0.000377	0.00101	CcSEcCtD
Guanfacine—Dermatitis—Triamcinolone—multiple sclerosis	0.000377	0.00101	CcSEcCtD
Guanfacine—Rash—Methylprednisolone—multiple sclerosis	0.000377	0.00101	CcSEcCtD
Guanfacine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000376	0.00101	CcSEcCtD
Guanfacine—Headache—Triamcinolone—multiple sclerosis	0.000375	0.001	CcSEcCtD
Guanfacine—Headache—Methylprednisolone—multiple sclerosis	0.000374	0.001	CcSEcCtD
Guanfacine—Abdominal pain—Prednisone—multiple sclerosis	0.000374	0.000999	CcSEcCtD
Guanfacine—Diarrhoea—Betamethasone—multiple sclerosis	0.000372	0.000993	CcSEcCtD
Guanfacine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000372	0.000993	CcSEcCtD
Guanfacine—Hypotension—Methotrexate—multiple sclerosis	0.000369	0.000987	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.00036	0.000962	CcSEcCtD
Guanfacine—Dizziness—Betamethasone—multiple sclerosis	0.000359	0.00096	CcSEcCtD
Guanfacine—Dizziness—Dexamethasone—multiple sclerosis	0.000359	0.00096	CcSEcCtD
Guanfacine—Insomnia—Methotrexate—multiple sclerosis	0.000358	0.000955	CcSEcCtD
Guanfacine—Nausea—Triamcinolone—multiple sclerosis	0.000356	0.00095	CcSEcCtD
Guanfacine—Paraesthesia—Methotrexate—multiple sclerosis	0.000355	0.000948	CcSEcCtD
Guanfacine—Nausea—Methylprednisolone—multiple sclerosis	0.000355	0.000948	CcSEcCtD
Guanfacine—Dyspnoea—Methotrexate—multiple sclerosis	0.000352	0.000942	CcSEcCtD
Guanfacine—Somnolence—Methotrexate—multiple sclerosis	0.000351	0.000939	CcSEcCtD
Guanfacine—Hypersensitivity—Prednisone—multiple sclerosis	0.000349	0.000931	CcSEcCtD
Guanfacine—Dyspepsia—Methotrexate—multiple sclerosis	0.000348	0.00093	CcSEcCtD
Guanfacine—Vomiting—Dexamethasone—multiple sclerosis	0.000345	0.000923	CcSEcCtD
Guanfacine—Vomiting—Betamethasone—multiple sclerosis	0.000345	0.000923	CcSEcCtD
Guanfacine—Decreased appetite—Methotrexate—multiple sclerosis	0.000344	0.000918	CcSEcCtD
Guanfacine—Rash—Betamethasone—multiple sclerosis	0.000343	0.000915	CcSEcCtD
Guanfacine—Rash—Dexamethasone—multiple sclerosis	0.000343	0.000915	CcSEcCtD
Guanfacine—Dermatitis—Betamethasone—multiple sclerosis	0.000342	0.000914	CcSEcCtD
Guanfacine—Dermatitis—Dexamethasone—multiple sclerosis	0.000342	0.000914	CcSEcCtD
Guanfacine—Fatigue—Methotrexate—multiple sclerosis	0.000341	0.000911	CcSEcCtD
Guanfacine—Headache—Dexamethasone—multiple sclerosis	0.00034	0.000909	CcSEcCtD
Guanfacine—Headache—Betamethasone—multiple sclerosis	0.00034	0.000909	CcSEcCtD
Guanfacine—Asthenia—Prednisone—multiple sclerosis	0.000339	0.000907	CcSEcCtD
Guanfacine—Pruritus—Prednisone—multiple sclerosis	0.000335	0.000894	CcSEcCtD
Guanfacine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000326	0.00087	CcSEcCtD
Guanfacine—Diarrhoea—Prednisone—multiple sclerosis	0.000324	0.000865	CcSEcCtD
Guanfacine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000323	0.000864	CcSEcCtD
Guanfacine—Nausea—Dexamethasone—multiple sclerosis	0.000323	0.000862	CcSEcCtD
Guanfacine—Nausea—Betamethasone—multiple sclerosis	0.000323	0.000862	CcSEcCtD
Guanfacine—Dizziness—Prednisone—multiple sclerosis	0.000313	0.000836	CcSEcCtD
Guanfacine—Abdominal pain—Methotrexate—multiple sclerosis	0.000313	0.000835	CcSEcCtD
Guanfacine—Vomiting—Prednisone—multiple sclerosis	0.000301	0.000803	CcSEcCtD
Guanfacine—Rash—Prednisone—multiple sclerosis	0.000298	0.000797	CcSEcCtD
Guanfacine—Dermatitis—Prednisone—multiple sclerosis	0.000298	0.000796	CcSEcCtD
Guanfacine—Headache—Prednisone—multiple sclerosis	0.000296	0.000792	CcSEcCtD
Guanfacine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000291	0.000778	CcSEcCtD
Guanfacine—Asthenia—Methotrexate—multiple sclerosis	0.000284	0.000758	CcSEcCtD
Guanfacine—Nausea—Prednisone—multiple sclerosis	0.000281	0.000751	CcSEcCtD
Guanfacine—Pruritus—Methotrexate—multiple sclerosis	0.00028	0.000747	CcSEcCtD
Guanfacine—Diarrhoea—Methotrexate—multiple sclerosis	0.000271	0.000723	CcSEcCtD
Guanfacine—Dizziness—Methotrexate—multiple sclerosis	0.000261	0.000698	CcSEcCtD
Guanfacine—Vomiting—Methotrexate—multiple sclerosis	0.000251	0.000671	CcSEcCtD
Guanfacine—Rash—Methotrexate—multiple sclerosis	0.000249	0.000666	CcSEcCtD
Guanfacine—Dermatitis—Methotrexate—multiple sclerosis	0.000249	0.000665	CcSEcCtD
Guanfacine—Headache—Methotrexate—multiple sclerosis	0.000248	0.000662	CcSEcCtD
Guanfacine—Nausea—Methotrexate—multiple sclerosis	0.000235	0.000627	CcSEcCtD
Guanfacine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	2.44e-05	0.00266	CbGpPWpGaD
Guanfacine—ADRA2A—G alpha (i) signalling events—CXCL10—multiple sclerosis	2.39e-05	0.00261	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR ligand binding—CXCR3—multiple sclerosis	2.36e-05	0.00258	CbGpPWpGaD
Guanfacine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	2.35e-05	0.00257	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—RGS1—multiple sclerosis	2.33e-05	0.00254	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR ligand binding—CCR2—multiple sclerosis	2.3e-05	0.00251	CbGpPWpGaD
Guanfacine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	2.29e-05	0.0025	CbGpPWpGaD
Guanfacine—ADRA2B—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	2.27e-05	0.00248	CbGpPWpGaD
Guanfacine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.26e-05	0.00247	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.25e-05	0.00246	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.25e-05	0.00246	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—GPR65—multiple sclerosis	2.2e-05	0.00241	CbGpPWpGaD
Guanfacine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	2.16e-05	0.00236	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR ligand binding—CNR1—multiple sclerosis	2.12e-05	0.00232	CbGpPWpGaD
Guanfacine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	2.11e-05	0.00231	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—RGS1—multiple sclerosis	2.11e-05	0.00231	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—S1PR1—multiple sclerosis	2.08e-05	0.00227	CbGpPWpGaD
Guanfacine—ADRA2A—G alpha (i) signalling events—CCL5—multiple sclerosis	2.06e-05	0.00225	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.05e-05	0.00224	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.05e-05	0.00224	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—CCR1—multiple sclerosis	2.02e-05	0.0022	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—CXCL13—multiple sclerosis	2.02e-05	0.0022	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—SRM—multiple sclerosis	2.01e-05	0.00219	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—SELE—multiple sclerosis	2.01e-05	0.00219	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—GPR65—multiple sclerosis	2e-05	0.00219	CbGpPWpGaD
Guanfacine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	1.95e-05	0.00212	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—LINGO1—multiple sclerosis	1.94e-05	0.00211	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR ligand binding—CCL3—multiple sclerosis	1.93e-05	0.00211	CbGpPWpGaD
Guanfacine—ADRA2A—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	1.92e-05	0.0021	CbGpPWpGaD
Guanfacine—ADRA2B—G alpha (i) signalling events—POMC—multiple sclerosis	1.91e-05	0.00209	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—ITGA4—multiple sclerosis	1.91e-05	0.00209	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR ligand binding—CXCL10—multiple sclerosis	1.91e-05	0.00209	CbGpPWpGaD
Guanfacine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	1.9e-05	0.00208	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—IFNB1—multiple sclerosis	1.9e-05	0.00207	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—S1PR1—multiple sclerosis	1.88e-05	0.00206	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR ligand binding—PTGER4—multiple sclerosis	1.86e-05	0.00203	CbGpPWpGaD
Guanfacine—ADRA2A—G alpha (i) signalling events—CCR5—multiple sclerosis	1.86e-05	0.00203	CbGpPWpGaD
Guanfacine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.84e-05	0.00201	CbGpPWpGaD
Guanfacine—ADRA2B—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	1.83e-05	0.002	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CXCL13—multiple sclerosis	1.83e-05	0.002	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CCR1—multiple sclerosis	1.83e-05	0.002	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR ligand binding—CXCR3—multiple sclerosis	1.79e-05	0.00196	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—RGS1—multiple sclerosis	1.76e-05	0.00193	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR ligand binding—CCR2—multiple sclerosis	1.74e-05	0.0019	CbGpPWpGaD
Guanfacine—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	1.72e-05	0.00188	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TAGAP—multiple sclerosis	1.68e-05	0.00183	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—GPR65—multiple sclerosis	1.67e-05	0.00183	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR ligand binding—CCL5—multiple sclerosis	1.64e-05	0.0018	CbGpPWpGaD
Guanfacine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	1.64e-05	0.00179	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR ligand binding—CNR1—multiple sclerosis	1.61e-05	0.00176	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—RGS1—multiple sclerosis	1.6e-05	0.00175	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—CCR1—multiple sclerosis	1.53e-05	0.00167	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—CXCL13—multiple sclerosis	1.53e-05	0.00167	CbGpPWpGaD
Guanfacine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	1.52e-05	0.00166	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—GPR65—multiple sclerosis	1.52e-05	0.00166	CbGpPWpGaD
Guanfacine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.49e-05	0.00163	CbGpPWpGaD
Guanfacine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	1.49e-05	0.00162	CbGpPWpGaD
Guanfacine—ADRA2B—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.48e-05	0.00162	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR ligand binding—CCR5—multiple sclerosis	1.48e-05	0.00162	CbGpPWpGaD
Guanfacine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	1.48e-05	0.00161	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LINGO1—multiple sclerosis	1.47e-05	0.0016	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—S1PR1—multiple sclerosis	1.47e-05	0.0016	CbGpPWpGaD
Guanfacine—ADRA2A—G alpha (i) signalling events—POMC—multiple sclerosis	1.45e-05	0.00158	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—ITGA4—multiple sclerosis	1.45e-05	0.00158	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR ligand binding—CXCL10—multiple sclerosis	1.45e-05	0.00158	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—IFNB1—multiple sclerosis	1.44e-05	0.00157	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—GPC5—multiple sclerosis	1.43e-05	0.00156	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—SRM—multiple sclerosis	1.42e-05	0.00155	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CYP24A1—multiple sclerosis	1.42e-05	0.00155	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CYP27B1—multiple sclerosis	1.42e-05	0.00155	CbGpPWpGaD
Guanfacine—ADRA2A—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	1.39e-05	0.00152	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CCR1—multiple sclerosis	1.39e-05	0.00152	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CXCL13—multiple sclerosis	1.39e-05	0.00152	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—PTGER4—multiple sclerosis	1.38e-05	0.00151	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—CXCR3—multiple sclerosis	1.34e-05	0.00146	CbGpPWpGaD
Guanfacine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	1.32e-05	0.00144	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—IL2RA—multiple sclerosis	1.31e-05	0.00143	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CCL3—multiple sclerosis	1.3e-05	0.00142	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—CCR2—multiple sclerosis	1.3e-05	0.00142	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—SRM—multiple sclerosis	1.3e-05	0.00142	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—GPC5—multiple sclerosis	1.29e-05	0.00141	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TAGAP—multiple sclerosis	1.27e-05	0.00139	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—PTGER4—multiple sclerosis	1.26e-05	0.00137	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR ligand binding—CCL5—multiple sclerosis	1.25e-05	0.00136	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—RGS1—multiple sclerosis	1.25e-05	0.00136	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CXCR3—multiple sclerosis	1.21e-05	0.00132	CbGpPWpGaD
Guanfacine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.2e-05	0.00131	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—CNR1—multiple sclerosis	1.2e-05	0.00131	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—GPR65—multiple sclerosis	1.18e-05	0.00129	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CCR2—multiple sclerosis	1.18e-05	0.00129	CbGpPWpGaD
Guanfacine—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.16e-05	0.00126	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR ligand binding—POMC—multiple sclerosis	1.16e-05	0.00126	CbGpPWpGaD
Guanfacine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	1.15e-05	0.00126	CbGpPWpGaD
Guanfacine—ADRA2B—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.14e-05	0.00124	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR ligand binding—CCL2—multiple sclerosis	1.13e-05	0.00124	CbGpPWpGaD
Guanfacine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	1.13e-05	0.00123	CbGpPWpGaD
Guanfacine—ADRA2A—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.13e-05	0.00123	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR ligand binding—CCR5—multiple sclerosis	1.12e-05	0.00123	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—S1PR1—multiple sclerosis	1.11e-05	0.00122	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CNR1—multiple sclerosis	1.09e-05	0.00119	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—GPC5—multiple sclerosis	1.08e-05	0.00118	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCR1—multiple sclerosis	1.08e-05	0.00118	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CXCL13—multiple sclerosis	1.08e-05	0.00118	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—CXCL10—multiple sclerosis	1.08e-05	0.00118	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—RRM1—multiple sclerosis	1.07e-05	0.00117	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PTGER4—multiple sclerosis	1.05e-05	0.00115	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—CXCR3—multiple sclerosis	1.01e-05	0.00111	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1e-05	0.0011	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1e-05	0.0011	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—IL2RA—multiple sclerosis	9.91e-06	0.00108	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CCL3—multiple sclerosis	9.9e-06	0.00108	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—CCR2—multiple sclerosis	9.86e-06	0.00108	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.8e-06	0.00107	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CXCL10—multiple sclerosis	9.8e-06	0.00107	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PTGER4—multiple sclerosis	9.53e-06	0.00104	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RGS1—multiple sclerosis	9.46e-06	0.00103	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—ALB—multiple sclerosis	9.44e-06	0.00103	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—CCL5—multiple sclerosis	9.29e-06	0.00101	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CXCR3—multiple sclerosis	9.2e-06	0.001	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GPC5—multiple sclerosis	9.17e-06	0.001	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	9.15e-06	0.000999	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	9.15e-06	0.000999	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—CNR1—multiple sclerosis	9.1e-06	0.000993	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—GPR65—multiple sclerosis	8.97e-06	0.00098	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CCR2—multiple sclerosis	8.95e-06	0.000977	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.94e-06	0.000976	CbGpPWpGaD
Guanfacine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	8.79e-06	0.000959	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR ligand binding—POMC—multiple sclerosis	8.78e-06	0.000959	CbGpPWpGaD
Guanfacine—ADRA2A—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	8.62e-06	0.000941	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR ligand binding—CCL2—multiple sclerosis	8.6e-06	0.000938	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SRM—multiple sclerosis	8.56e-06	0.000935	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CCL5—multiple sclerosis	8.44e-06	0.000921	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—CCR5—multiple sclerosis	8.37e-06	0.000914	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GPC5—multiple sclerosis	8.37e-06	0.000913	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CNR1—multiple sclerosis	8.26e-06	0.000902	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—IL2RA—multiple sclerosis	8.25e-06	0.000901	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CXCL13—multiple sclerosis	8.21e-06	0.000896	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCR1—multiple sclerosis	8.21e-06	0.000896	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—CXCL10—multiple sclerosis	8.19e-06	0.000894	CbGpPWpGaD
Guanfacine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	7.93e-06	0.000866	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCL3—multiple sclerosis	7.71e-06	0.000841	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—IL2—multiple sclerosis	7.65e-06	0.000836	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CCR5—multiple sclerosis	7.6e-06	0.00083	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—RRM1—multiple sclerosis	7.6e-06	0.00083	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL2RA—multiple sclerosis	7.49e-06	0.000818	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CXCL10—multiple sclerosis	7.44e-06	0.000812	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PTGER4—multiple sclerosis	7.42e-06	0.00081	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PGR—multiple sclerosis	7.31e-06	0.000798	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CXCR3—multiple sclerosis	7.16e-06	0.000782	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—ALB—multiple sclerosis	7.16e-06	0.000782	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CD28—multiple sclerosis	7.1e-06	0.000775	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—CCL5—multiple sclerosis	7.05e-06	0.00077	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCR2—multiple sclerosis	6.97e-06	0.000761	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—RRM1—multiple sclerosis	6.93e-06	0.000757	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—POMC—multiple sclerosis	6.54e-06	0.000714	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CNR1—multiple sclerosis	6.43e-06	0.000702	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CCL5—multiple sclerosis	6.4e-06	0.000699	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—CCR5—multiple sclerosis	6.35e-06	0.000693	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	6.26e-06	0.000683	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—BCHE—multiple sclerosis	6.16e-06	0.000673	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	6.03e-06	0.000659	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	6.03e-06	0.000659	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—TGFB1—multiple sclerosis	5.97e-06	0.000652	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—POMC—multiple sclerosis	5.94e-06	0.000649	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.9e-06	0.000644	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—MAPK1—multiple sclerosis	5.86e-06	0.000639	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCL3—multiple sclerosis	5.85e-06	0.000638	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CCL2—multiple sclerosis	5.81e-06	0.000635	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—IL2—multiple sclerosis	5.81e-06	0.000634	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CXCL10—multiple sclerosis	5.79e-06	0.000632	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CCR5—multiple sclerosis	5.77e-06	0.00063	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL2RA—multiple sclerosis	5.69e-06	0.000621	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PTGER4—multiple sclerosis	5.63e-06	0.000614	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	5.54e-06	0.000605	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GPC5—multiple sclerosis	5.52e-06	0.000602	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	5.44e-06	0.000593	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	5.39e-06	0.000588	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.38e-06	0.000587	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	5.29e-06	0.000577	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—TYK2—multiple sclerosis	5.28e-06	0.000576	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.07e-06	0.000553	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CD86—multiple sclerosis	5.06e-06	0.000553	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCL5—multiple sclerosis	4.99e-06	0.000544	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	4.96e-06	0.000542	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	4.88e-06	0.000533	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—IL2—multiple sclerosis	4.84e-06	0.000528	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.62e-06	0.000504	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.62e-06	0.000504	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SPP1—multiple sclerosis	4.62e-06	0.000504	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—RRM1—multiple sclerosis	4.57e-06	0.000499	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	4.53e-06	0.000495	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	4.51e-06	0.000492	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCR5—multiple sclerosis	4.49e-06	0.00049	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	4.44e-06	0.000485	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL2RA—multiple sclerosis	4.43e-06	0.000483	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	4.41e-06	0.000482	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	4.39e-06	0.00048	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL2—multiple sclerosis	4.39e-06	0.00048	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—BCHE—multiple sclerosis	4.37e-06	0.000477	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.21e-06	0.00046	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	4.09e-06	0.000446	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	4.01e-06	0.000437	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—BCHE—multiple sclerosis	3.98e-06	0.000435	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	3.84e-06	0.000419	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	3.78e-06	0.000413	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—APOE—multiple sclerosis	3.71e-06	0.000405	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	3.69e-06	0.000403	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	3.67e-06	0.000401	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	3.51e-06	0.000383	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	3.5e-06	0.000382	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	3.43e-06	0.000375	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	3.41e-06	0.000372	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	3.36e-06	0.000367	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	3.36e-06	0.000367	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	3.33e-06	0.000364	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—POMC—multiple sclerosis	3.19e-06	0.000348	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	3.12e-06	0.00034	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	3.1e-06	0.000338	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ALB—multiple sclerosis	2.9e-06	0.000317	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	2.8e-06	0.000306	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	2.66e-06	0.000291	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOE—multiple sclerosis	2.63e-06	0.000287	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—BCHE—multiple sclerosis	2.63e-06	0.000287	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	2.61e-06	0.000284	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	2.6e-06	0.000283	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	2.58e-06	0.000282	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	2.55e-06	0.000278	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	2.46e-06	0.000268	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOE—multiple sclerosis	2.4e-06	0.000261	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	2.37e-06	0.000258	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—POMC—multiple sclerosis	2.26e-06	0.000246	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	2.18e-06	0.000238	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—POMC—multiple sclerosis	2.06e-06	0.000225	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ALB—multiple sclerosis	2.06e-06	0.000225	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	2.03e-06	0.000222	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	2.02e-06	0.000221	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	1.99e-06	0.000217	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	1.97e-06	0.000215	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	1.96e-06	0.000214	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ALB—multiple sclerosis	1.88e-06	0.000205	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	1.86e-06	0.000203	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	1.66e-06	0.000181	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOE—multiple sclerosis	1.58e-06	0.000172	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	1.54e-06	0.000168	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	1.54e-06	0.000168	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	1.53e-06	0.000167	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	1.51e-06	0.000164	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—POMC—multiple sclerosis	1.36e-06	0.000148	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALB—multiple sclerosis	1.24e-06	0.000135	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	1.16e-06	0.000126	CbGpPWpGaD
